Benzinga's Small Cap Movers for Thursday February 28, 2013
Below are highlights from Benzinga's daily coverage of small cap securities making big moves:
Wireless Ronin Technologies
Shares of Wireless Ronin Technologies (NASDAQ: RNIN), the Minneapolis, MN digital marketing technologies company, rose 108% Thursday on 108 times average volume.
Wireless Ronin Technologies has aligned with Samsung Electronics America, the number one worldwide provider of commercial LCD displays, to offer a breakthrough in digital signage solutions for retail, QSRs or any business looking to transform how they engage their customers and increase sales without the cost, complication and limitations of traditional digital signage.
"We're excited to partner with Samsung as one of the earliest adopters of their Smart Signage Platform," said Scott Koller, president and CEO of Wireless Ronin. "Despite the clear and compelling benefits digital marketing can deliver, deploying digital signage, especially across multiple locations, can seem like a daunting and expensive project. RoninCast 4.0 software, combined with Samsung's new Smart Signage Platform, dramatically simplifies deployment and ongoing management, breaking down these barriers and opening the field to a much larger universe of potential users."
Wireless Ronin Technologies closed at $4.28 on Thursday.
Institutional Financial Markets
Institutional Financial Markets (NYSE: IFMI), the Philadelphia, PA financial services firm specializing in credit-related fixed income investments, rose 65% Thursday on 87 times average volume.
Institutional Financial Markets reported Wednesday financial results for its fourth quarter and year ended December 31, 2012. Adjusted operating income was $4.3 million, or $0.26 per diluted share, for the three months ended December 31, 2012, compared to adjusted operating income of $0.3 million, or $0.02 per diluted share, for the three months ended December 31, 2011, and adjusted operating income of $4.4 million, or $0.27 per diluted share, for the three months ended September 30, 2012. Adjusted operating income was $7.5 million, or $0.47 per diluted share, for the year ended December 31, 2012, compared to adjusted operating income of $3.5 million, or $0.22 per diluted share, for the year ended December 31, 2011.
Institutional Financial Markets closed at $2.75 on Thursday.
Shares of Neogenomics (NASDAQ: NEO), the Fort Meyers, FL provider of cancer-focused genetic testing services, rose 6.5% Thursday on almost 19 times average volume.
NeoGenomics announced Thursday that it has priced an underwritten public offering of 3.15 million shares of common stock at a price to the public of $3.00 per share. Of the shares offered, NeoGenomics is selling 2.85 million shares and a selling stockholder, The Mary S. Dent Gifting Trust, is selling 300,000 shares. The transaction is expected to close on March 5, 2013 and will result in gross proceeds to NeoGenomics of $8.6 million. The net proceeds to the Company, after deducting the underwriter's discounts and other estimated offering expenses, will be approximately $7.8 million.
Neogenomics closed at $1.70 on Thursday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.